PEAK6 Investments’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-82,437
Closed -$3.16M 4054
2024
Q1
$3.16M Buy
82,437
+50,632
+159% +$2.45M 0.01% 1117
2023
Q4
$2.14M Buy
31,805
+15,422
+94% +$1.07M 0.01% 1463
2023
Q3
$1.23M Buy
+16,383
New +$1.45M 0.01% 1671
2023
Q2
Sell
-5,194
Closed -$462K 4358
2023
Q1
$538K Sell
5,194
-10,856
-68% -$1.2M ﹤0.01% 2331
2022
Q4
$1.85M Buy
16,050
+9,470
+144% +$1.1M 0.01% 1383
2022
Q3
$713K Buy
+6,580
New +$943K ﹤0.01% 2538
2022
Q1
Sell
-959
Closed -$181K 5664
2021
Q4
$201K Sell
959
-2,085
-68% -$431K ﹤0.01% 4009
2021
Q3
$587K Buy
3,044
+3,041
+101,367% +$748K ﹤0.01% 3105
2021
Q2
$1K Sell
3
-3,593
-100% -$974K ﹤0.01% 4964
2021
Q1
$762K Buy
+3,596
New +$861K ﹤0.01% 2819
2019
Q4
Sell
-3,233
Closed -$335K 3773
2019
Q3
$335K Buy
+3,233
New +$347K ﹤0.01% 2568
2019
Q2
Sell
-9,244
Closed -$1.28M 4043
2019
Q1
$1.18M Buy
+9,244
New +$1.17M 0.01% 1717

Other funds holding MED

PEAK6 Investments's MED Position: Q2 2024 in Review

PEAK6 Investments sold out of Medifast (MED) in Q2 2024, closing a stake of 82,437 shares — an estimated $3.16M sold.

PEAK6 Investments first reported a position in MED in Q1 2019 and held it in 12 quarters. The position peaked at $3.16M in Q1 2024. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • PEAK6 Investments reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 82,437 Medifast shares in Q2 2024, an estimated $3.16M.
  • PEAK6 Investments first reported a position in Medifast in Q1 2019 and held it in 12 quarters.
  • PEAK6 Investments's Medifast position peaked at $3.16M in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.